Growth Metrics

Novartis Ag (NVS) FCF Margin (2009 - 2024)

Novartis Ag recorded quarterly FCF Margin of 41.04% in Q2 2024, up 31.51% quarter-over-quarter from 31.21% in Q4 2023, and up 2674.0% year-over-year from 1.48% in Q3 2023.

Novartis Ag's FCF Margin history runs 13 years deep, the most recent figure standing at 41.04% for Q2 2024.

  • In Q2 2024, FCF Margin rose 2674.0% year-over-year to 41.04%; the TTM figure through Jun 2024 stood at 35.56% (down 169.0% YoY), while the FY2025 annual figure was 32.27%, down 3.0% from the prior year.
  • FCF Margin came in at 41.04% for Q2 2024 at Novartis Ag, up from 31.21% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 2896.69% in Q4 2020 to a low of 14.3% in Q2 2023.
  • A 5-year average of 375.23% and a median of 69.7% in 2021 frame the typical range for FCF Margin.
  • Across the five-year window, FCF Margin tumbled 288070 bps in 2021 and soared 223204 bps in 2022, its largest moves.
  • Novartis Ag's FCF Margin stood at 2896.69% in 2020, then tumbled by 99 bps to 15.99% in 2021, then surged by 13957 bps to 2248.03% in 2022, then plunged by 99 bps to 31.21% in 2023, then soared by 32 bps to 41.04% in 2024.
  • According to Business Quant data, FCF Margin over the past three periods registered 41.04%, 31.21%, and 14.3% for Q2 2024, Q4 2023, and Q2 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 15.19%
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 6.09%
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 23.76%
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn 17.97%
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn 17.14%
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 34.87%
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn 93.16%
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 6.59%
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2024 41.04%
Dec 31, 2023 31.21%
Jun 30, 2023 14.30%
Mar 31, 2023 51.85%
Dec 31, 2022 2,248.03%
Sep 30, 2022 93.64%
Jun 30, 2022 16.01%
Mar 31, 2022 100.00%
Dec 31, 2021 15.99%
Sep 30, 2021 155.31%
Jun 30, 2021 17.75%
Mar 31, 2021 87.54%
Dec 31, 2020 2,896.69%
Sep 30, 2020 117.23%
Jun 30, 2020 17.95%
Mar 31, 2020 99.16%
Jun 30, 2019 10.74%
Mar 31, 2019 120.00%
Dec 31, 2018 194.74%
Sep 30, 2018 115.69%
Jun 30, 2018 15.06%
Mar 31, 2018 121.70%
Dec 31, 2017 315.84%
Sep 30, 2017 198.96%
Jun 30, 2017 2,027.98%
Dec 31, 2016 1.22%
Sep 30, 2016 236.90%
Jun 30, 2016 281.76%
Mar 31, 2016 203,703,703.70%
Dec 31, 2015 1,158.46%
Sep 30, 2015 399,310,344,827,586.19%
Mar 31, 2015 312.67%
Dec 31, 2014 954.02%
Sep 30, 2014 718.28%
Mar 31, 2014 580.72%
Dec 31, 2010 4,739,770.41%
Jun 30, 2010 3,030.04%
Dec 31, 2009 94,313,790.96%
Jun 30, 2009 29,423.48%
Mar 31, 2009 23.91%